Apiam Animal Health Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Apiam Animal Health ha aumentado sus beneficios a una tasa media anual de 1.5%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 1.5% anual. Los ingresos han ido creciendo a una tasa media de 13.7% al año. La rentabilidad financiera de Apiam Animal Health es de 2.1%, y sus márgenes netos son de 1.3%.

Información clave

1.5%

Tasa de crecimiento de los beneficios

-7.7%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	2.4%
Tasa de crecimiento de los ingresos	13.7%
Rentabilidad financiera	2.1%
Margen neto	1.3%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Recent updates

Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%

Feb 24

These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively

Oct 12

Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004

Sep 02

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Feb 28

Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being

Nov 18

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price

Mar 12

Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)

Feb 25

How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?

Feb 08

Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Jan 18

Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?

Dec 28

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price

Dec 11

Is Apiam Animal Health Limited (ASX:AHX) The Right Choice For A Smart Dividend Investor?

Nov 24

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Apiam Animal Health. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

ASX:AHX Ingresos, gastos y beneficios (AUD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	202	3	0
30 Sep 23	197	2	0
30 Jun 23	192	2	0
31 Mar 23	184	4	0
31 Dec 22	176	6	0
30 Sep 22	166	5	0
30 Jun 22	157	5	0
31 Mar 22	149	4	0
31 Dec 21	140	4	1
30 Sep 21	133	5	1
30 Jun 21	126	5	2
31 Mar 21	125	5	2
31 Dec 20	123	5	2
30 Sep 20	121	5	2
30 Jun 20	118	4	2
31 Mar 20	115	4	2
31 Dec 19	112	3	2
30 Sep 19	112	3	2
30 Jun 19	112	3	2
31 Mar 19	112	3	2
31 Dec 18	112	3	2
30 Sep 18	109	3	2
30 Jun 18	107	3	2
31 Mar 18	105	3	1
31 Dec 17	103	4	1
30 Sep 17	100	4	1
30 Jun 17	98	5	1
31 Mar 17	94	5	2
31 Dec 16	90	5	2
30 Sep 16	72	3	2
30 Jun 16	54	0	1

Ingresos de calidad: AHX tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(1.3%) de AHX son inferiores a los del año pasado (3.3%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de AHX han crecido un 1.5% al año en los últimos 5 años.

Acelerando crecimiento: AHX ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: AHX tuvo un crecimiento negativo de los beneficios (-54%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (-19.1%).

Rentabilidad financiera

Alta ROE: La rentabilidad financiera de AHX (2.1%) se considera baja.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Apiam Animal Health Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Información clave

Actualizaciones de resultados anteriores recientes

Apiam Animal Health Limited to Report First Half, 2024 Results on Feb 23, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Apiam Animal Health Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

First half 2023 earnings released: EPS: AU$0.017 (vs AU$0.013 in 1H 2022)

Apiam Animal Health Limited to Report First Half, 2023 Results on Feb 24, 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Recent updates

MD & Executive Director recently bought AU$596k worth of stock

Upcoming dividend of AU$0.01 per share

Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%

Apiam Animal Health Limited to Report First Half, 2024 Results on Feb 23, 2024

Apiam Animal Health Limited, Annual General Meeting, Nov 23, 2023

These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively

MD & Executive Director recently bought AU$134k worth of stock

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

New minor risk - Financial data availability

Apiam Animal Health Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

Consensus EPS estimates fall by 17%

Price target decreased by 8.0% to AU$0.86

First half 2023 earnings released: EPS: AU$0.017 (vs AU$0.013 in 1H 2022)

Apiam Animal Health Limited to Report First Half, 2023 Results on Feb 24, 2023

Apiam Animal Health Limited (ASX:AHX) acquired Hunter Equine Centre Pty Ltd for AUD 6.5 million.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harradine and Associates for AUD 2.6 million.

Apiam Animal Health Limited, Annual General Meeting, Nov 24, 2022

MD & Executive Director recently sold AU$354k worth of stock

Price target increased to AU$1.13

Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Apiam Animal Health Limited to Report Fiscal Year 2022 Results on Aug 29, 2022

Consensus forecasts updated

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire assets of Victorian Equine Group and Romsey Veterinary Surgery for AUD 13.75 million.

Insufficient new directors

Upcoming dividend of AU$0.012 per share

Consensus forecasts updated

First half 2022 earnings: EPS misses analyst expectations

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Apiam Animal Health Limited Announces Ordinary Fully Franked Dividend for the Period Ended December 31, 2021, Payable on April 20, 2022

Apiam Animal Health Limited to Report First Half, 2022 Results on Feb 25, 2022

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Fraser Coast Veterinary Services.

Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being

MD & Executive Director recently bought AU$96k worth of stock

Apiam Animal Health (ASX:AHX) Has Announced A Dividend Of AU$0.012

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Harbour City Veterinary Surgery.

Insufficient new directors

Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012

Full year 2021 earnings released: EPS AU$0.042 (vs AU$0.037 in FY 2020)

Price target increased to AU$0.85

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Harbour City Veterinary Surgery for AUD 2.8 million.

Apiam Animal Health Limited (ASX: AHX) acquired Assets of Golden Plains Animal Hospital.

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire The Scenic Rim for AUD 16 million.

A Look At The Fair Value Of Apiam Animal Health Limited (ASX:AHX)

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Samford Valley Veterinary Hospital.

Apiam Animal Health Limited (ASX:AHX) acquired Clermont Veterinary Surgery.

MD & Executive Director recently bought AU$252k worth of stock

With EPS Growth And More, Apiam Animal Health (ASX:AHX) Is Interesting

Only Four Days Left To Cash In On Apiam Animal Health's (ASX:AHX) Dividend

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price

Upcoming Dividend of AU$0.012 Per Share

New 90-day high: AU$0.74

Analysts update estimates

Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)

First half 2021 earnings released: EPS AU$0.022 (vs AU$0.015 in 1H 2020)

Apiam Animal Health Limited to Report First Half, 2021 Results on Feb 24, 2021

How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?

Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

New 90-day low: AU$0.57

Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?

New 90-day low: AU$0.60

Price target lowered to AU$0.59

Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price

New 90-day high: AU$0.74

Apiam Animal Health Limited (ASX:AHX) completed the acquisition of Crosvet Pty Ltd.

Apiam Animal Health Limited Announces Executive Changes, Effective November 30, 2020

Is Apiam Animal Health Limited (ASX:AHX) The Right Choice For A Smart Dividend Investor?

Apiam Animal Health Limited (ASX:AHX) entered into an agreement to acquire Crosvet Pty Ltd for AUD 5 million.

Desglose de ingresos y gastos
Beta